Synchronous Dual-Cycle Amplification System Based on Programmable Ago-DNA Polymerase for Detecting Tumor-Related MicroRNAs
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.4c05564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Qiuyuan Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Technology for Precision Medicine, School of Medical Technology and Engineer…. Hauptthemen laut MEDLINE: MicroRNAs, Nucleic Acid Amplification Techniques, DNA-Directed DNA Polymerase, Argonaute Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Fujian Medical University, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Detecting nucleic acid biomarkers is essential for early cancer diagnosis and monitoring. Traditional methods (e.g., exponential isothermal amplification (EXPAR)) adopt DNA polymerases and endonucleases for nucleic acid amplification and analysis, but they are limited by the dependence on specific sequences and nonspecific amplification. Here, we establish a programmable and universal nucleic acid diagnostic platform named Functional Junction Molecule Unveil (FJMU) for microRNAs detection. FJMU incorporates Argonaute (Ago) nuclease and DNA polymerase to accomplish nucleic acid detection in a single reaction. It utilized a specially designed repetitive sequence template to achieve synchronized dual-cycling amplification of biomarkers. The FJMU method eliminates the reliance on restriction endonucleases such as Nt.BstNBI used in EXPAR. FJMU showed high specificity and stability in detecting colorectal cancer-related microRNAs. A comparison of the detection results between the FJMU method and the reverse transcription-polymerase chain reaction (RT-PCR) for clinical serum samples suggests that the FJMU method is potentially feasible for clinical applications. FJMU provided a programmable platform for detecting microRNAs and further explored the Ago-mediated nucleic acid detection technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Technology for Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350005, China.
- School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China.
- Department of Clinical Laboratory, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
- Department of Pharmaceutical Analysis, The School of Pharmacy, Fujian Medical University, Fuzhou 350005, China.
ORCID-Profile: Qiuyuan Lin, Jinghua Chen
Förderung
- Fujian Medical University
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
- Fujian Province
Zitieren
APA
Lin, Q., Huang, Y., Chen, J., Lei, Z., Yang, M., Kudouluke, M., Su, G., & Chen, J. (2025). Synchronous Dual-Cycle Amplification System Based on Programmable Ago-DNA Polymerase for Detecting Tumor-Related MicroRNAs. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c05564
Vancouver
Lin Q, Huang Y, Chen J, Lei Z, Yang M, Kudouluke M, et al. Synchronous Dual-Cycle Amplification System Based on Programmable Ago-DNA Polymerase for Detecting Tumor-Related MicroRNAs. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.4c05564
BibTeX
@article{Lin2025,
author = {Lin, Qiuyuan and Huang, Yicheng and Chen, Junchao and Lei, Zhenxin and Yang, Mingwei and Kudouluke, Mierhaitireye and Su, Guangjian and Chen, Jinghua},
title = {Synchronous Dual-Cycle Amplification System Based on Programmable Ago-DNA Polymerase for Detecting Tumor-Related MicroRNAs},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.4c05564}
}
EUVIMED